Omnicell (OMCL) FCF Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Omnicell (OMCL) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 194.00 |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 984.00 |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 641.00 |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 66.00 |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 119.00 |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 1,788.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -177.00 |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -395.00 |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -1,013.00 |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 836.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 836.00 |
| Mar 31, 2026 | 810.00 |
| Dec 31, 2025 | -818.00 |
| Sep 30, 2025 | 104.00 |
| Jun 30, 2025 | -710.00 |
| Mar 31, 2025 | -1,118.00 |
| Dec 31, 2024 | 405.00 |
| Sep 30, 2024 | -1,061.00 |
| Jun 30, 2024 | -274.00 |
| Mar 31, 2024 | 1,575.00 |
| Dec 31, 2023 | -1,167.00 |
| Sep 30, 2023 | 1,311.00 |
| Jun 30, 2023 | 2,628.00 |
| Mar 31, 2023 | 953.00 |
| Dec 31, 2022 | 739.00 |
| Sep 30, 2022 | -978.00 |
| Jun 30, 2022 | -2,991.00 |
| Mar 31, 2022 | -2,940.00 |
| Dec 31, 2021 | -1,283.00 |
| Sep 30, 2021 | -307.00 |